GERMANY PHARMACEUTICAL INSURANCE DEAL
April 1st, 2006
STORIES BY KEITH NUTHALL
THE EUROPEAN Commission has insisted that German insurer Talanx sells off some of its pharmaceutical industry insurance interests as a condition of being given permission to buy rival insurance group Gerling. Acting as an international competition regulator, the Commission found that both Talanx subsidiary HDI and Gerling have "a very strong position" in insuring German medicine manufacturers. An unfettered deal could "significantly reduce competition as regards liability insurance for pharmaceutical companies in ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.